EPISODE · Apr 14, 2026 · 12 MIN
Raymond James Biotech Innovation Symposium: Dyne's CEO John Cox shares an overview of the company's recent landmark DMD data
from BiotechTV - News · host BiotechTV
He describes both the biomarker and functional benefits seen in the December data for the company's next-generation exon 51 skipping therapy.
What this episode covers
He describes both the biomarker and functional benefits seen in the December data for the company's next-generation exon 51 skipping therapy.
NOW PLAYING
Raymond James Biotech Innovation Symposium: Dyne's CEO John Cox shares an overview of the company's recent landmark DMD data
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m